Orchestra BioMed Holdings (OBIO) executive compensation, 2026 proxy

David P. Hochman, Chief Executive Officer & Chairman, was paid $2.3M in fiscal 2025, up 18% from $1.9M the year before.

Filed
April 29, 2026
Annual meeting
June 23, 2026
Pay year
fiscal 2025
Named executives
3
CEO total pay
$2.3M+18% vs prior year
CEO pay in equity
48%$1.1M in awards
CEO Target Bonus
80%Percentage of base salary
CFO Target Bonus
50%Percentage of base salary
2025 Corporate Achievement
120.17%Achievement level for bonus payout
Peer Group Size
18Companies used for benchmarking

How Hochman was paid

$2.3M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary26%Stock awards35%Option awards13%Non-equity incentive25%All other compensation1%

Named executive officers

ExecutiveTotal
David P. HochmanChief Executive Officer & Chairman$2,261,233
Darren R. ShermanPresident & Chief Operating Officer$1,757,835
Andrew L. TaylorChief Financial Officer$1,206,517

What changed and why

  • $2.3MCEO total compensation increased to $2,261,233 in 2025 compared to $1,912,475 in 2024.
  • Base salaries for Messrs.
  • Hochman and Sherman remained unchanged from the prior year.
  • $430KCFO Andrew L. Taylor received a salary increase in August 2025 to $430,000.
  • Annual non-equity incentive bonuses were awarded based on achievement of corporate and individual goals.
  • 120.17%Corporate goals and objectives were achieved at a 120.17% level for the 2025 fiscal year.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.